Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

CPRX holding history

Catalyst Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CPRX overviewAll 13F holders of CPRXFull Q2 2026 holdings

Shares (Q2 2026)
134,531
Value
$4.23M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of CPRX by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026134,531$4.23M<0.1%+93,989+231.8%AddedHolders
Q1 202640,542$1.00M<0.1%+29,762+276.1%AddedHolders
Q4 202510,780$251.6K<0.1%−94,341−89.7%ReducedHolders
Q3 2025105,121$2.07M<0.1%+31,149+42.1%AddedHolders
Q2 202573,972$1.61M<0.1%−26,423−26.3%ReducedHolders
Q1 2025100,395$2.43M<0.1%+82,222+452.4%AddedHolders
Q4 202418,173$379.3K<0.1%+18,173NewHolders
Q2 20240$00.0%−12,261−100.0%Sold outHolders
Q1 202412,261$195.4K<0.1%−38,658−75.9%ReducedHolders
Q4 202350,919$855.9K<0.1%−101,149−66.5%ReducedHolders
Q3 2023152,068$1.78M<0.1%−223,550−59.5%ReducedHolders
Q2 2023375,618$5.05M<0.1%−803,804−68.2%ReducedHolders
Q1 20231,179,422$19.6M<0.1%−444,544−27.4%ReducedHolders
Q4 20221,623,966$30.2M0.1%−241,059−12.9%ReducedHolders
Q3 20221,865,025$23.9M<0.1%+437,975+30.7%AddedHolders
Q2 20221,427,050$10.0M<0.1%+385,083+37.0%AddedHolders
Q1 20221,041,967$8.64M<0.1%+470,180+82.2%AddedHolders
Q4 2021571,787$3.87M<0.1%+166,929+41.2%AddedHolders
Q3 2021404,858$2.15M<0.1%−47,480−10.5%ReducedHolders
Q2 2021452,338$2.60M<0.1%+301,946+200.8%AddedHolders
Q1 2021150,392$693.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.